State of Wyoming’s ChemoCentryx, Inc. CCXI Stock Holding History

State of Wyoming’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,013	Closed	-$25K	–	2103
2022 Q2	$25K	Sell	1,013 -412	-29%	-$9.08K	0.02%	1360
2022 Q1	$36K	Buy	1,425 +1,409	+8,806%	+$39.6K	0.02%	1234
2021 Q4	$1K	Buy	+16	New	+$562	﹤0.01%	1847
2021 Q3	–	Sell	-56	Closed	-$1K	–	1378
2021 Q2	$1K	Buy	56 +30	+115%	+$739	﹤0.01%	1164
2021 Q1	$1K	Buy	+26	New	+$1.56K	﹤0.01%	505

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

State of Wyoming's CCXI Position: Q3 2022 in Review

State of Wyoming sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 1,013 shares — an estimated $25K sold.

State of Wyoming first reported a position in CCXI in Q1 2021 and held it in 5 quarters. The position peaked at $36K in Q1 2022. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

State of Wyoming reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 1,013 ChemoCentryx, Inc. shares in Q3 2022, an estimated $25K.
State of Wyoming first reported a position in ChemoCentryx, Inc. in Q1 2021 and held it in 5 quarters.
State of Wyoming's ChemoCentryx, Inc. position peaked at $36K in Q1 2022.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.